A fundamental point of star ratings is balancing the interest of patients with that of taxpayers, says Dr. Don Rucker, former ONC head and current chief strategy officer of 1upHealth.

Virtual AI agent Anna offers consumers a safe space to ask questions and make payments, says Dugan Winkie, head of Commercial Strategy at Cedar.

A rare combination of skill sets in AI is required: standing up a large AI governance structure, managing a portfolio of AI for myriad patients, overseeing AI in clinical and business environments, and more, UC Davis Health's AI chief says.

AKASA has found a return of $1.5 million in recovered additional revenue per each $1 billion of total patient revenue, says CEO and cofounder Malinka Walaliyadde.

In recent years, Thai healthcare providers have emphasised mobile solutions to enhance the patient experience, notes Dr Korpong Rookkapan of Bumrungrad International Hospital.

Mark Polyak, president of analytics at Ipsos, says consumers recognize the promise of easier access to treatment and cost information, and they're comfortable with AI doing administrative tasks. But they’re more cautious about clinical applications.

Dr. Chethan Sarabu, AI & informatics strategist at OpenNotes, discusses how genAI and LLMs can offer patients new tools to help them navigate and understand their healthcare journeys, from diagnosis to treatment.

Christine Antorini, former minister of education for Denmark and current nursing student, says mobile-friendly EHRs and AI tools that fit into nurses' workflows can foster better nurse-patient relationships.

According to Dr. Gerald Lip of the UK's NHS Grampian, AI technology reduces radiologists' workloads by 30% and can help improve patient outcomes by detecting small tumors that experienced human readers might not see.

Alexander Berler of IHE Catalyst explains how the organization educates vendors about the eHealth European Interoperability Framework and helps them test their products for different patient scenarios.

Dr. Diana van Stijn, Lapsi Health CMO, says digital health companies should work with healthcare professionals, patients and each other to develop new tools that are both usable and marketable.

Orr Inbar, cofounder and CEO of QuantHealth, discusses how the company helps pharma implement AI for drug development using clinical trial simulation and the long-term effects of AI on drug development for positive patient outcomes.